G. Simpson, K. Yadalam, D. Levinson
Dec 1, 1990
Citations
0
Influential Citations
21
Citations
Quality indicators
Journal
Journal of clinical psychopharmacology
Abstract
Fluphenazine decanoate is commonly used as part of maintenance treatment of schizophrenia, but its pharmacokinetics are poorly understood. We administered a single intramuscular dose of fluphenazine decanoate to nine patients and found that plasma fluphenazine level did not decline to 50% of the peak level by day 26 in any of the patients. This means that it has a long half-life measurable in months rather than weeks.